JPRN-UMIN000015244已完成未知
Effect of switching from tiotropium to glycopyrronium on pulmonary function in patients with COPD. - Effect of switching from tiotropium to glycopyrronium on pulmonary function in patients with COPD.
KKR Takamatsu hospital0 个研究点目标入组 30 人开始时间: 2014年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients who need systemic corcicosteroidal administration and/or hospitalization for COPD exacerbation within 16 weeks prior to enrollment 2)patients having lower respiratory infection within 16weeks prior to enrollment 3)patients with home oxygen therapy 4)patients with bronchial asthma or chronic respiratory disease such as bronchiectasis,pulmonary fibrosis and pneumoconiosis 5)patients with uncontrolled severe complications 6)patients who seem inadequate for this study by investigators
研究者
相似试验
已完成
不适用
The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.Chronic obstructive pulmonary disease (COPD)JPRN-UMIN000017301Department of Respiratory Medicine, Shizuoka General Hospital60
已完成
不适用
The effectiveness of switching to Tiotropium / Olodaterol combination in patients with COPDCOPDJPRN-UMIN000025049Shizuoka General Hospital57
尚未招募
不适用
A study to compare the effect on tolerance with or without medication (Glycopyrrolate) in patients undergoing upper gastrointestinal endoscopy without sedatioCTRI/2020/07/026786Jawaharlal Institute of Postgraduate Medical Education and Research
已完成
4 期
Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPDCOPDNCT01959516Novartis Pharmaceuticals124
已完成
4 期
Study on utilization of glycopyrronium and arformoterol inhalation as a treatment for COPD.CTRI/2019/07/020144Glenmark Pharmaceuticals Ltd49